# Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis

> **NCT01795872** · PHASE4 · COMPLETED · sponsor: **Bayer** · enrollment: 278 (actual)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **PROCEDURE:** Several diagnostic procedures

## Key facts

- **NCT ID:** NCT01795872
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09
- **Primary completion:** 2014-04
- **Final completion:** 2014-06
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2015-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01795872

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01795872, "Follow-up Study After 11 Years of Patients Who Were Included in the BENEFIT Trial (304747) With a First Demyelinating Event Suggestive of Multiple Sclerosis". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01795872. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*